Aurobindo Pharma Ltd. (AUROPHARMA) - Financials, balance sheet (annual)

1,139.5 INR

14.7

1.27%

Last update Jul 18, 3:29 PM IST

Market closed

Day range

1,139.5

1,136.69995

1,155.80005

Previous close

1,154.19995

Open

1,155

Access this stock data via API

Aurobindo Pharma Ltd.

1,139.50

14.70

1.27%

Financials

Balance sheet

Fiscal date	2025	2024	2023	2022
Total assets	497.8B	450.7B	398.9B	339.2B
Current assets	271.6B	242.1B	215.5B	181.2B
Cash	—	13.8B	18.0B	35.3B
Cash equivalents	—	20.1B	25.9B	6.3B
Cash and cash equivalents	55.7B	33.9B	44.0B	41.6B
Other short term investments	29.3B	29.3B	18.3B	4.0B
Accounts receivable	57.5B	48.2B	44.7B	40.1B
Other receivables	155.6M	5.3B	5.5B	3.7B
Inventory	105.4B	98.1B	85.1B	75.5B
Prepaid assets	—	22.9B	16.8B	12.3B
Restricted cash	—	37.1M	115.7M	112.2M
Assets held for sale	0	4.3B	857.6M	791M
Hedging assets	—	34.5M	191.4M	320.2M
Other current assets	23.6B	25.4B	18.7B	15.6B
Non current assets	226.2B	208.7B	183.4B	158.0B
Properties	121.9B	115.5B	80.0B	7.0B
Land and improvements	—	9.8B	9.5B	7.8B
Machinery furniture equipment	—	120.2B	90.1B	79.7B
Construction in progress	32.7B	28.7B	48.1B	30.4B
Leases	—	—	—	—
Accumulated depreciation	—	-63.7B	-55.6B	-38.7B
Goodwill	48.6B	46.7B	45.2B	40.9B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	36.2B	34.8B	33.3B	31.4B
Investments and advances	—	—	—	—
Other non current assets	2.9B	2.3B	45.3M	100K
Total liabilities	171.4B	152.2B	130.4B	93.5B
Current liabilities	146.8B	122.0B	114.9B	81.6B
Accounts payable	41.9B	44.5B	38.7B	27.0B
Accrued expenses	—	—	—	—
Short term debt	64.6B	42.6B	43.5B	27.1B
Deferred revenue	—	—	—	—
Tax payable	2.8B	2.5B	2.1B	580.3M
Pensions	—	2.6B	2.0B	1.7B
Other current liabilities	5.5B	2.8B	2.2B	1.3B
Non current liabilities	24.6B	30.2B	15.4B	11.9B
Long term provisions	2.8B	2.3B	1.7B	1.7B
Long term debt	18.0B	23.9B	9.4B	5.7B
Provision for risks and charges	—	1.2M	290.4M	297.7M
Deferred liabilities	3.0B	3.6B	3.9B	4.1B
Derivative product liabilities	—	—	—	—
Other non current liabilities	545.4M	364.7M	-15.2B	297.7M
Shareholders equity
Common stock	580.8M	585.9M	585.9M	585.9M
Retained earnings	—	268.0B	240.1B	225.2B
Other shareholders equity	—	—	—	—
Total shareholders equity	326.5B	298.5B	268.5B	245.7B
Additional paid in capital	—	5.3B	4.3B	4.3B
Treasury stock	—	—	—	—
Minority interest	-63.9M	80M	120M	-19.3M